InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: retired early post# 40103

Saturday, 01/21/2017 8:10:01 PM

Saturday, January 21, 2017 8:10:01 PM

Post# of 203913
And here's exactly how we'll get to $100 PPS (my bold):

Multiple Myeloma (Cancer)
• Designed to be an Orphan Disease study approved by the FDA
• In-vitro study completed 06/2015 – Cannabis kills the MM cancer cells
• Pre-clinic study on mice completed 12/2015 – calibration phase for dosage,
found most effective ratio of active cannabinoids THC/CBD
• In-vitro study for a combination of 4 approved drugs with cannabis completed
05/2016 – promising results
• Pre-clinic study for the most effective combination on mice with new cannabis
extracts. On-going testing.
SUBJECT TO ACHIEVING SCIENTIFIC MILESTONES THE COMPANY WILL
SUBMITT AN APPLICATION WITH THE FDA FOR AN ORPHAN DISEASE
DESIGNATION



Page 12 of the newest PowerPoint.
http://www.owcpharma.com/wp-content/uploads/2017/01/OWC-PPT-1-2017-FINAL.pdf